Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Unusual Epigenetic Regulator Could Impact Cancer
Scientific Advances

Unusual Epigenetic Regulator Could Impact Cancer

By Will DossNov 9, 2020
Share
Facebook Twitter Email
Ali Shilatifard, PhD, the Robert Francis Furchgott Professor and chair of Biochemistry and Molecular Genetics, was senior author of the study published in Genes and Development.

Northwestern Medicine scientists have discovered a “hidden” function of an epigenetic regulator, publishing their findings in the journal Genes and Development.

The regulator, a methyltransferase called Trr, helps stabilize a genetic domain called UTX. UTX is often mutated in cancers, raising the possibility that this regulatory pathway could be used to slow the growth of cancer, according to Ali Shilatifard, PhD, the Robert Francis Furchgott Professor, chair of Biochemistry and Molecular Genetics and senior author of the study.

“If we can somehow stabilize UTX in cancer cells, that could be a targeted therapeutic,” said Shilatifard, also a professor of Pediatrics, director of the Simpson Querrey Institute for Epigenetics and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Trr is one of three enzymes that make up the COMPASS family of proteins in Drosophila flies. COMPASS is an important epigenetic regulatory complex, determining which genes are expressed when.

The human equivalent of Trr — MLL3/4 — is often mutated in cancers, generating significant scientific interest in Trr’s activity. A previous study from the Shilatifard laboratory made the surprising discovery that Trr’s enzymatic function was not actually essential for proper development, raising the possibility that Trr affected gene expression through a different mechanism.

“We showed that you can have life without this activity,” Shilatifard said. “But now you have this 4,000 amino acid-long protein — where is the business end?”

In the current study, the scientists performed a series of genetic screens, isolating different sections of the protein and testing if the flies survived with only that section. They whittled the “important” stretch of the protein down to just one domain: a series of amino acids that bound to and stabilized a protein called UTX.

Investigating this domain in the human equivalent of Trr — MLL3/4 — Shilatifard and his colleagues found it matched the pattern of gene expression seen in the fly models, binding to UTX.

“These experiments were months in the making and I was not even certain the screen would work; however, the day I identified the ‘essential’ Trr domain was truly exhilarating,” said Ryan Rickels, PhD, a former doctoral student in the Shilatifard laboratory and lead author of the study. “After showing Trr’s methyltransferase activity was dispensable, it was really exciting to see the scientific process play out and eventually uncover the domain that stabilizes UTX.”

In many human cancers, MLL3/4 is mutated and dysfunctional, causing UTX to be unstable. According to Shilatifard, this may be a critical point in the cancer-causing mechanism of MLL3/4 mutations, and finding a way to stabilize UTX could be an effective treatment for these cancers.

Next, Shilatifard said he hopes to further investigate the function of UTX and search for drug compounds that could help stabilize the protein.

“We are following our noses and these results, trying to find a mechanism that can be applied in development of targeted therapeutics,” Shilatifard said.

This study was supported by National Institutes of Health/National Cancer Institute (NCI) grants F99CA222988A, K99CA234434P and R50CA211428, and in part by NCI Outstanding Investigator Award R35CA197569.

Biochemistry and Molecular Genetics Cancer Genetics Research
Share. Facebook Twitter Email

Related Posts

Fathers’ Presence During Childhood Predicts Adult Testosterone Levels

Jun 29, 2022

Epigenetic Biomarkers Predict CVD Risk

Jun 28, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Comments are closed.

Latest News

Fathers’ Presence During Childhood Predicts Adult Testosterone Levels

Jun 29, 2022

Epigenetic Biomarkers Predict CVD Risk

Jun 28, 2022

Student Spearheads Ukraine Aid Efforts

Jun 27, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220617_NM_0434
20220617_NM_0858
20220617_NM_0643
20220617_NM_0835
20220617_NM_0544
20220617_NM_0450
20220617_NM_0790
20220617_NM_0811
20220617_NM_0851
20220617_NM_0696
20220617_NM_0779
20220617_NM_0838

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.